Immunic, inc. to announce financial results for the third quarter ended september 30, 2022, and provide corporate update

– webcast to be held at 8:00 am et on november 3, 2022 – new york , oct. 27, 2022 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced that the company will release its financial results for the third quarter ended september 30, 2022, including a corporate update, on thursday, november 3, 2022, before the opening of the u.s. financial markets. a webcast will follow at 8:00 am et.
IMUX Ratings Summary
IMUX Quant Ranking